Eevia Health Plc received a 228 kSEK / 21 kEUR sales order for a Bilberry extract product

Eevia received a new repeat order from a German customer for a bilberry extract. The German customer develops and markets vegan vitamins, superfoods, and sports nutrition under well-known brands. They use high quality raw materials in their own, innovative recipes.  The company maintains strict quality control and exclusively vegan products.

The sales value to Eevia of this new order is c. kEUR 21 EUR, which Eevia has in stock. The product is Eevia's branded ingredient Feno-Myrtillus® 36 Organic, which is a highly concentrated and organically certified bilberry extract with 36% anthocyanins.

The order is expected to be followed by further repeat orders in the future.

 

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com  or investor@eeviahealth.com                     

Telephone: +358 400 22 5967                         

 

 

 

 

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth. 

 

Datum 2023-12-20, kl 08:09
Källa Cision
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!